Ad
related to: patient teaching for lactulose doseGoodRx was honored as dot.LA’s Startup of the Year for 2020. - dot.LA
Search results
Results from the WOW.Com Content Network
Lactulose is used in the treatment of chronic constipation in patients of all ages as a long-term treatment. [13] The dosage of lactulose for chronic idiopathic constipation is adjusted depending on the constipation severity and desired effect, from a mild stool softener to causing diarrhea.
Lactulose is a carbohydrate that is not absorbed by humans. Lactulose is well known to measure oro-cecal transit time. [11] [1] [4] The mean oro-cecal transit time in normal healthy individuals is 70 to 90 minutes. [12] [13] [8] By 90 minutes, at least 50% of individuals would have delivered the lactulose dose to the colon. Approximately 90 to ...
Patient education is a planned interactive learning process designed to support and enable expert patients [1] to manage their life with a disease and/or optimise their health and well-being. [ 2 ] [ 3 ]
It is still available to physicians for patients in emergency situations that are life-threatening or require hospitalization. [ 16 ] Prucalopride (brand name Resolor) is a current drug approved for use in the EU since October 15, 2009, [ 17 ] in Canada (brand name Resotran) since December 7, 2011, [ 18 ] and in the United States since December ...
ATC code A06 Drugs for constipation is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Patient education and a good doctor–patient relationship are an important part of care. [7] [21] About 10–15% of people in the developed world are believed to be affected by IBS. [1] [11] The prevalence varies according to country (from 1.1% to 45.0%) and criteria used to define IBS; however the average global prevalence is 11.2%. [12]
The WHO Model List of Essential Medicines (aka Essential Medicines List or EML [1]), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe to meet the most important needs in a health system. [2]
Docusate is the common chemical and pharmaceutical name of the anion bis(2-ethylhexyl) sulfosuccinate, also commonly called dioctyl sulfosuccinate (DOSS). [2] [3] [4]Salts of this anion, especially docusate sodium, are widely used in medicine as an emollient laxative and as stool softeners, by mouth or rectally. [1]